ArticleBMC infectious diseases2025
Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveThe study aimed to understand the drug resistance profile and transmission characteristics of drug-resistant Mycobacterium tuberculosis (MTB) in Ganzhou, China, to provide a scientific basis for developing prevention and control strategies.
methodsDNA extracted from re-cultured positive strains underwent whole-genome sequencing (WGS). The online platform SAM-TB was used to identify drug resistance-related mutations in each strain, construct a phylogenetic tree, and calculate the pairwise strain single-nucleotide polymorphism (SNP) distances. A threshold of 12 SNPs between pairwise strains was set to identify transmission clusters. Epidemiological investigations were conducted for patients within these transmission clusters to analyze the characteristics of drug-resistant tuberculosis (TB) transmission.
resultsA total of 82 strains were analyzed. The most common mutations observed for isoniazid, rifampicin, ethambutol, and streptomycin were katG (S315T, 32/61), rpoB (S450L, 13/37), embB (M306V, 5/12), and rpsL (K43R, 18/26), respectively. Mutations were also observed in genes conferring resistance to other drugs, including pncA (pyrazinamide), gyrA (ofloxacin), rrs, and eis (aminoglycosides). The strains belonged to lineage 2 (75.61%, 62/82) and 4 (24.39%, 20/82). Three clusters containing 12 drug-resistant strains were identified as transmission clusters, ranging in size from 2 to 8, with a clustering rate of 14.63% (12/82). Notably, lineage 2 strains were more prevalent in clustered cases than lineage 4 strains (19.35%, 12/62 vs. 0%, 0/20, Fisher’s exact test, P = 0.033). The isoniazid resistance rate was significantly higher in clustered strains (100%, 12/12) than in non-clustered strains (70.00%, 49/70) (Fisher’s exact test, P = 0.031). Two potential transmission chains of drug-resistant TB were identified.
conclusionThis study utilized WGS technology to provide important data on the genetic mutation types and transmission dynamics of drug-resistant TB in Ganzhou. WGS demonstrates significant potential in early prediction of drug resistance in TB and identification of recent transmission events, offering essential support for monitoring public health events and intervening in drug-resistant tuberculosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.